Company: INMB
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001213900-25-033742
Chunk: 14

Company: Inmune Bio, Inc.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 14
---

“ FOR ” THIS PROPOSAL NO. 3. 10 PROPOSAL 4 — NON-BINDING ADVISORY VOTE ON THE FREQUENCY OF FUTURE
NON-BINDING ADVISORY VOTES ON FUTURE NAMED EXECUTIVE OFFICER COMPENSATION In Proposal 3 above, the Company is asking its stockholders to vote on a non -bindingadvisory resolution on named executive officer compensation and the Company will provide this type of advisory vote at least once every three years. Pursuant to Section 14A of the Exchange Act and the related rules of the SEC, in this Proposal 4, the Company is asking its stockholders to vote on the frequency of future non -bindingadvisory votes on named executive officer compensation. The Board of Directors believes that an advisory vote on executive compensation every three years is the most appropriate policy for the Company at this time, and recommends that stockholders vote for future non -bindingadvisory votes on named executive officer compensation to occur every three years. While our named executive officer compensation programs are designed to promote a long -termconnection between pay and performance, and the Board of Directors recognizes that named executive officer compensation disclosures are made annually, the rules of the SEC permit the Company to solicit this advisory vote only every three years and the Company believes that management time and attention is better served by soliciting this advisory vote only every three years. Pursuant to this non -bindingadvisory vote on the frequency of future non -bindingadvisory votes on named executive officer compensation, stockholders will be able to specify one of four choices for this proposal on the proxy card or voting instruction: one year, two years, three years or abstain. Stockholders are not voting to approve or disapprove the Board of Director’s recommendation. The vote is non -bindingon the Board of Directors. Nevertheless, the Board of Directors and the compensation committee will carefully review the voting results. Notwithstanding the Board of Director’s recommendation and the outcome of the stockholder vote, the Board of Directors may in the future decide to conduct advisory votes on a more or less frequent basis and may vary its practice based on factors such as discussions with stockholders and the adoption of material changes to compensation programs. No Appraisal Rights No appraisal rights are available under the Nevada Revised Statutes or under our Articles of Incorporation or Bylaws with respect to Proposal 4. Interests of Officers and Directors in this Proposal Our officers and directors have a direct interest in in this Proposal